stella
beta
Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma — Stella
Recruiting
Back to Esophageal Squamous Cell Carcinoma (ESCC) trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
Sun yat-sen University Cancer Center, Guangzhou, Guangdong
View full record on ClinicalTrials.gov